Two NIMR scientists elected as Academy of Medical Sciences fellows

01 May 2008

Two NIMR scientists, Steve Gamblin and Victor Tybulewicz, have been elected as fellows of the Academy of Medical Sciences.

Academy Fellows are elected for outstanding contributions to the advancement of medical science, for innovative application of scientific knowledge and conspicuous service to healthcare. This year forty new Fellows have been elected to the Academy. The Admission Ceremony for new Fellows will take place on 24 June at the Royal Society in London.

Professor Sir John Bell, President of the Academy of Medical Sciences said, ‘These Fellows enter the Academy at a time when health and medical science issues are high on the public and political agenda. Our Fellows demonstrate the wealth of experience and diversity of talent amongst the UK’s research community. Their excellence in medical research plays a pivotal role in determining the future of medical science and the benefits that society will enjoy in years to come.’

Steve Gamblin

Steve Gamblin is joint head of NIMR's Division of Molecular Structure. His research interests focus on using X-ray crystallography and biochemical approaches in order to understand molecular recognition and signalling events. Current work is aimed at understanding the regulation of chromatin structure, the regulation of cellular energy metabolism and, in collaboration with the Institute's virologists, characterising the two major surface glycoproteins of the influenza virus.

Victor Tybulewicz

Victor Tybulewicz (pictured above) is head of NIMR's Division of Immune Cell Biology. He is interested in signal transduction from the antigen receptors of B and T cells (BCR and TCR respectively). To study this process, he has used gene targeting in ES cells and transgenic techniques to generate mouse strains carrying defined mutations in genes encoding proteins implicated in the signal transduction pathways. He also recently created a novel "transchromosomic" mouse line, Tc1, which is a model of trisomy 21, better known as Down syndrome (DS) in humans.

News archive

Top of page

© MRC National Institute for Medical Research
The Ridgeway, Mill Hill, London NW7 1AA